Sibannac, Inc. (SNNC) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
2122 E. HIGHLAND AVENUE, SUITE 425 PHOENIX, AZ 85016 |
| State of Incorp. | NV |
| Fiscal Year End | August 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 2/28/2017 MRQ | 8/31/2016 | 8/31/2015 | 8/31/2014 | 8/31/2013 | 8/31/2012 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 9 | 274 | 63 | 4 | 1 | |||
| Cash and cash equivalent | 9 | 274 | 63 | 4 | 1 | |||
| Receivables | 60 | 1 | ||||||
| Inventory, net of allowances, customer advances and progress billings | 20 | 118 | ||||||
| Inventory | 20 | 118 | ||||||
| Other current assets | 4 | ✕ | ||||||
| Other undisclosed current assets | 22 | 11 | ||||||
| Total current assets: | 73 | 275 | 63 | 46 | 130 | |||
| Noncurrent Assets | ||||||||
| Property, plant and equipment | 26 | 41 | ||||||
| Intangible assets, net (including goodwill) | 119 | 40 | ✕ | ✕ | ||||
| Intangible assets, net (excluding goodwill) | 119 | 40 | ||||||
| Other undisclosed noncurrent assets | 131 | 250 | 130 | 10 | ||||
| Total noncurrent assets: | 250 | 290 | 156 | 51 | ||||
| TOTAL ASSETS: | 323 | 565 | 63 | 202 | 181 | |||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities, including: | 54 | 23 | 72 | 240 | ||||
| Interest and dividends payable | 20 | 20 | ||||||
| Employee-related liabilities | 2 | 2 | ||||||
| Other undisclosed accounts payable and accrued liabilities | 33 | 70 | 240 | |||||
| Debt | 234 | 234 | ||||||
| Due to related parties | 7 | |||||||
| Other undisclosed current liabilities | 71 | |||||||
| Total current liabilities: | 366 | 257 | 72 | 240 | ||||
| Noncurrent Liabilities | ||||||||
| Liabilities, other than long-term debt | 250 | 250 | ||||||
| Accounts payable and accrued liabilities | 250 | 250 | ||||||
| Total noncurrent liabilities: | 250 | 250 | ||||||
| Other undisclosed liabilities | 65 | 413 | 464 | |||||
| Total liabilities: | 616 | 507 | 138 | 653 | 464 | |||
| Equity | ||||||||
| Equity, attributable to parent, including: | (293) | 58 | (75) | (451) | (284) | |||
| Common stock | 18 | 18 | 2 | 5 | 5 | |||
| Common stock, value, subscriptions | 63 | ✕ | ✕ | |||||
| Additional paid in capital | 41 | 41 | 791 | 131 | 131 | |||
| Accumulated deficit | (351) | (868) | (587) | (420) | ||||
| Other undisclosed equity, attributable to parent | (63) | |||||||
| Total equity: | (293) | 58 | (75) | (451) | (284) | |||
| TOTAL LIABILITIES AND EQUITY: | 323 | 565 | 63 | 202 | 181 | |||
Income Statement (P&L) ($ in thousands)
| 2/28/2017 TTM | 8/31/2016 | 8/31/2015 | 8/31/2014 | 8/31/2013 | 8/31/2012 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 524 | 207 | 288 | ||||
| Cost of revenue (Cost of Product and Service Sold) | (453) | (170) | (196) | ||||
| Other undisclosed gross profit | 147 | 135 | |||||
| Gross profit: | 70 | 184 | 227 | ||||
| Operating expenses | (270) | (2,375) | (70) | (329) | (449) | ||
| Other undisclosed operating income | 2,241 | ||||||
| Operating loss: | (199) | (133) | (70) | (145) | (221) | ||
| Nonoperating expense (Other Nonoperating expense) | (152) | ||||||
| Interest and debt expense | (31) | (22) | 13 | ||||
| Loss from continuing operations: | (382) | (133) | (70) | (168) | (208) | ||
| Income (loss) before gain (loss) on sale of properties: | (382) | 524 | (281) | (168) | (208) | ||
| Income (loss) from discontinued operations | 657 | (211) | |||||
| Other undisclosed net loss | (2,899) | ||||||
| Net loss: | (382) | (2,375) | (281) | (168) | (208) | ||
| Other undisclosed net income (loss) attributable to parent | 31 | 0 | (26) | ||||
| Net loss available to common stockholders, diluted: | (351) | (2,374) | (281) | (168) | (234) | ||
Comprehensive Income ($ in thousands)
| 2/28/2017 TTM | 8/31/2016 | 8/31/2015 | 8/31/2014 | 8/31/2013 | 8/31/2012 | ||
|---|---|---|---|---|---|---|---|
| Net loss: | (382) | (2,375) | (281) | (168) | (208) | ||
| Comprehensive loss, net of tax, attributable to parent: | (382) | (2,375) | (281) | (168) | (208) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.